Pharmalittle: How to improve FDA side-effect database; will pharma embrace Snapchat?

G

ood morning, everyone, and welcome to the middle of the week. You made it this far, so why not carry on? Our survival plan calls for quaffing a cup or three of delicious stimulation. As always, you are welcome to join us. Remember — no prescription is required. So time to get cracking. After all, there are meetings, phone calls, and deadlines awaiting. To help you along, we have gathered a menu of tidbits. We hope you find them helpful. Meanwhile, have a wonderful day and do stay in touch …

A new paper offers a few ideas for improving the adverse-event reporting system run by the Food and Drug Administration, Regulatory Focus says. The suggestions include automatically mapping drugs by ingredient to make it easier to identify trends and sift through the noise inherent in the database. The authors also say that introducing automation to the reports themselves could cut down on the number of erroneous or misclassified reports.

 

Source; https://www.statnews.com/pharmalot/2017/08/30/fda-side-effects-snapchat/

Leave a Reply